BioMed Central on Twitter BioMed Central on Facebook
  • About
  • Blogs
    • On Biology
    • On Medicine
    • On Health
    • On Society
    • On Physical Sciences
    • Research in progress blog
    • BMC Series blog
    • BugBitten
  • Topics
    • Biology
    • Medicine
    • Health
    • Chemistry
    • Physics
    • Developing World
    • Open Access
    • Technology
    • Publishing

Author Profile

  • About
  • Latest Posts
Klodeta Kura
Dr Klodeta Kura is a mathematical modeller working at the Department of Infectious Disease Epidemiology at Imperial College London, UK,where she models the transmission of schistosomiasis. Within Dr Kura's work, using deterministic and individual-based stochastic models, she assesses the effect of MDA and examines whether we can achieve the WHO goals of morbidity control and elimination by using the current guidelines. In cases where these guidelines do not appear to be sufficient, programmatic adaptations are suggested that could be implemented to increase the probability of achieving the WHO goals. Dr Kura is also working on assessing the impact of a candidate vaccine (Sm-p80), used either alone or in combination with MDA, when applied in endemic regions with different intensities of transmission.
Latest posts by Klodeta Kura (see all)
  • Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni - 22nd July 2022
  • The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination? - 22nd December 2020
  • The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination? - 22nd December 2020

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni

22/07/2022

BugBitten

Using two individual-based stochastic models, developed independently by the Imperial College London (ICL) and University of Oxford (SCHISTOX), and data from… Read more »

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?

Figure 1: Distribution of S. haematobium in Africa in 2018 as reported by the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN). Green = prevalence

22/12/2020

BugBitten

Using an individual based stochastic model and data from two different age-intensity profiles of infection prevalence and intensity, we explore the effect of… Read more »

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?

Figure 1: Distribution of S. haematobium in Africa in 2018 as reported by the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN). Green = prevalence

22/12/2020

BugBitten

Using an individual based stochastic model and data from two different age-intensity profiles of infection prevalence and intensity, we explore the effect of… Read more »

Our blogs

  • Research in progress blog
  • BMC Series blog
  • BugBitten
  • GigaBlog (archived)
  • On Biology
  • On Health
  • On Medicine
  • On Physical Sciences
  • On Society

Topics

  • Biology
  • Chemistry
  • Computer Science
  • Developing World
  • Earth & Environmental Science
  • Engineering
  • Health
  • Material Science
  • Medical Evidence
  • Medicine
  • Open Access
  • Physical Sciences
  • Physics
  • Publishing
  • Social Science
  • Technology
  • Uncategorised
  • Uncategorized

Latest BioMed Central Articles

Visit BioMed Central >

About

  • About our blog network
  • Copyright information
  • Community Guidelines
  • About BioMed Central

Network Blogs

  • On Biology
  • On Medicine
  • On Health
  • On Society
  • On Physical Sciences
  • Research in progress blog
  • BMC Series blog
  • Bugbitten

Related Blogs

  • SpringerOpen blog

Network Topics

  • Biology
  • Medicine
  • Health
  • Developing World
  • Open Access
  • Technology
  • Publishing

Community

  • Network RSS Feeds
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow us on LinkedIn
  • Follow us on YouTube

By continuing to use this website, you agree to our Terms and Conditions, Community Guidelines, Privacy statement and Cookies policy.

Springer Nature logo

© 2017 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.